After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets

After the Rally: Pfizer's COVID Booster vs. O...

Up next

CNBC Investing Club: Cramer’s Morning Take on Arm Holdings 4/24/26

Cramer says this chipmaker giant’s products will see strong demand for many years. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charit ...  Show more

SOTS 2nd Hour: Powell DOJ Probe Gets Dropped & Tech's Tear Higher 4/24/26

Breaking news this hour: The Department of Justice is dropping its criminal probe of Fed Chair Powell. Hear David Faber, Sara Eisen, and Michael Santoli break the story - along with more on what it means for Fed Chair Nominee Kevin Warsh, the markets, yields, and the dollar... wi ...  Show more

Recommended Episodes

Magnificent Seven Stocks: What’s Going on With Apple, Tesla, and Alphabet?
Investing Insights

Sarah Hansen, Morningstar Inc markets reporter, explains why Apple and Tesla are diverging from the rest of the Magnificent Seven stocks. Also, details into a first ever dividend from Alphabet. Preston Caldwell, senior US economist for Morningstar Research Services, discusses ...

  Show more

Musk’s Cheaper EVs Calm Fears Over Tesla Strategy
Bloomberg Businessweek

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Technology Co-Host Ed Ludlow discusses Tesla easing concerns about disappointing earnings results and diminished growth by vowing to launch less-expensive vehicles as soon as late this year. Bloomberg ...  Show more

Apple Intelligence
Wall Street Breakfast

Apple (AAPL) unveils new Apple Intelligence, iOS, tvOS at WWDC. (00:24) CVS generics recalled two times more than Walgreens (WBA) generics: report. (02:09) DXC Technology jumps on report of joint bid from Apollo (APO), Kyndryl (KD). (03:16) Episode transcripts seekingalpha.com/ws ...  Show more

Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
Real Vision: Finance & Investing

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more